Full Name

Dr. Phil Collis

Position

SVP, Development

Quote

Quotient Sciences’ real-time manufacturing capabilities were a key factor in determining the speed at which this study could be concluded, offering the rare combination or GMP manufacturing and clinical administration on the same site, even for complex formulations and dosage forms. This allowed us to progress much faster.

Company

BioCryst Pharmaceuticals